Everest Medicines (Beijing) Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Everest Medicines (Beijing) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients (NCT07614646) | Everest Medicines (Beijing) Co., Ltd. | 2026-07-01 |
| Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors (NCT07095868) | Everest Medicines (Beijing) Co., Ltd. | 2025-11-17 |
Track Everest Medicines (Beijing) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.